Myriad Genetics (MYGN) Shareholder's Equity (2010 - 2026)
Myriad Genetics (MYGN) Shareholder's Equity (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 15.29 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 51.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 52.95 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 1.56 Bn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 1.77 Bn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -202.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 6.35 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2.68 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -41.88 Mn |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 337.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 337.40 Mn |
| Dec 31, 2025 | 368.00 Mn |
| Sep 30, 2025 | 372.80 Mn |
| Jun 30, 2025 | 388.10 Mn |
| Mar 31, 2025 | 704.90 Mn |
| Dec 31, 2024 | 701.10 Mn |
| Sep 30, 2024 | 731.70 Mn |
| Jun 30, 2024 | 740.50 Mn |
| Mar 31, 2024 | 760.00 Mn |
| Dec 31, 2023 | 783.20 Mn |
| Sep 30, 2023 | 683.40 Mn |
| Jun 30, 2023 | 735.20 Mn |
| Mar 31, 2023 | 835.20 Mn |
| Dec 31, 2022 | 885.80 Mn |
| Sep 30, 2022 | 916.60 Mn |
| Jun 30, 2022 | 947.40 Mn |
| Mar 31, 2022 | 950.10 Mn |
| Dec 31, 2021 | 967.80 Mn |
| Sep 30, 2021 | 968.50 Mn |
| Jun 30, 2021 | 902.40 Mn |